Heavy Medicine Holdings: Subsidiary issued the first phase of 500 million yuan medium-term notes due in 2026.

Chongqing Pharmaceutical Holdings announced that its subsidiary, Chongqing Pharmaceutical Co., Ltd., completed the issuance of the first tranche of medium-term notes for the year 2026 on March 25th, with funds received on March 26th. The notes are abbreviated as "26 Chongqing Medicine MTN001", have a term of 2 years, and both the planned and actual issuance amount are 500 million yuan. The issuance interest rate is 1.91%. The lead underwriter is China Everbright Bank, with joint lead underwriters as Bank of China. As of now, Chongqing Pharmaceutical has issued two tranches of medium-term notes, with a total issuance amount of 1 billion yuan and a remaining amount of 1 billion yuan.